EDGAR Filing Documents for 0001104659-21-152914

Form 8-K - Current report:

SEC Accession No. 0001104659-21-152914

Filing Date

2021-12-23

Accepted

2021-12-23 09:00:24

Documents

Period of Report

2021-12-22

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2136177d1_8k.htm iXBRL	8-K	48160
2	EXHIBIT 10.1	tm2136177d1_ex10-1.htm	EX-10.1	11152
	Complete submission text file	0001104659-21-152914.txt		239107

Data Files

Seq	Description	Document	Type	Size
3	XBRL TAXONOMY EXTENSION SCHEMA	ptpi-20211222.xsd	EX-101.SCH	3037
4	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ptpi-20211222_lab.xml	EX-101.LAB	34240
5	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ptpi-20211222_pre.xml	EX-101.PRE	22367
7	EXTRACTED XBRL INSTANCE DOCUMENT	tm2136177d1_8k_htm.xml	XML	3728

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036

Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005

Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)